Curium Announces a Strategic Investment of Over €32 million in Saclay, France

Curium’s strategic investment of over €32 million will establish a European production line for 177Lu-PSMA-I&T, a therapeutic ...

Lantheus weighs potential $7 billion sale after Curium's offer, Bloomberg News reports

May 22 (Reuters) - Radiopharmaceutical-focused company Lantheus Holdings is weighing a potential sale after getting a ...
Yahoo Finance

Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.

ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m ...
Fierce Pharma

Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg

A multi-billion-dollar acquisition within the radiopharmaceutical space could be percolating as Lantheus Holding considers a ...

Lantheus Holdings gains after report it's evaluating a sale after offer

Lantheus Holdings (LNTH) quickly rose 7.4% on a report that it's evaluating a sale after receiving a takeover offer from Curium that values the radiopharma firm at about $7 billion. Lantheus (LNTH) ...
manilatimes

Curium strengthens its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

The acquisition of Nucleis will: Enhance Curium's PET manufacturing capacity and radiopharmaceutical distribution network of 32 PET sites in Western Europe Improve reliability and accessibility of ...
The National Law Review

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Positions Curium as leading manufacturer of Lu-177 isotope Brings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET geographical coverage and supply chain PARIS, March 28, ...